Richard Lane, MD
Retina Specialist · San Antonio, TXNPI 1922086347
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (38.2%), ownership interests and food and beverage — rather than concentrated in one kind of arrangement. US Retina LLC accounts for 66.9% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2022 at $9,468 and has fallen 90.5% since, to $899 in 2025.
Across 103 payments — averaging $168.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- US Retina LLC$12K
- Eyepoint US, Inc.$2K
- Genentech USA, Inc.$573
- Avirmax Biopharma, Inc$454
- Alcon$412
- Harrow Eye, LLC$392
- plus $2K from 21 others
Across 1,810 payments — averaging $2594.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$1.9M
- Ocular Therapeutix, Inc.$846K
- Bayer$672K
- AstraZeneca$499K
- Boehringer Ingelheim$275K
- Genentech, Inc.$186K
- plus $339K from 7 others
What the payments were for
- Travel & lodging$1,91311%
- Food & beverage$3,68421%
- Gifts$1691%
- Ownership interest$4,98329%
- Other$6,65238%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| US Retina LLC | 7 | $11,635 |
| Eyepoint US, Inc. | 7 | $2,200 |
| Genentech USA, Inc. | 18 | $573 |
| Avirmax Biopharma, Inc | 5 | $454 |
| Alcon | 4 | $412 |
| Harrow Eye, LLC | 2 | $392 |
| AbbVie(2 entities) | 12 | $354 |
| Regeneron Healthcare Solutions, Inc. | 12 | $301 |
| Optovue, Inc. | 1 | $120 |
| Janssen Global Services, LLC | 1 | $114 |
| Sun Pharmaceutical Industries Inc. | 1 | $104 |
| Bausch & Lomb Americas Inc. | 4 | $93 |
| Genentech, Inc. | 1 | $86 |
| Alimera Sciences, Inc. | 5 | $83 |
| Apellis Pharmaceuticals, Inc. | 4 | $74 |
| Biogen | 4 | $71 |
| Astellas Pharma US Inc | 2 | $61 |
| ANI Pharmaceuticals, Inc. | 2 | $54 |
| Ocular Therapeutix, Inc. | 2 | $46 |
| AstraZeneca | 1 | $43 |
| Mallinckrodt Hospital Products Inc. | 2 | $38 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Halozyme Inc | 1 | $16 |
| Vyera Pharmaceuticals, LLC | 1 | $15 |
| Spark Therapeutics, Inc. | 1 | $15 |
| Novartis | 1 | $14 |
| Shire North American Group Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,401 in reported general payments places this provider in the 85th percentile of 108 retina specialist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 188 | $7,553 |
| Difluprednate | 45 | $4,479 |
| Ketorolac Tromethamine | 46 | $2,126 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 75 | $1,019 |
| Tobramycin | 101 | $503 |
| Brimonidine Tartrate | 32 | $436 |
| MoxifloxacinMoxifloxacin Hcl | 20 | $393 |
| ErythromycinErythromycin Base | 17 | $182 |
| Timolol Maleate | 15 | $109 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in San Antonio
- Moises ChicaSan Antonio$43K
- Sarah HolySan Antonio$18K
- Duncan FriedmanSan Antonio$9K
- Thomas OeiSan Antonio$9K
- Timothy ClelandSan Antonio$6K
- Lina MaroufSan Antonio$4K
- Dianne BarrettSan Antonio$4K
- Abumere AkinwaleSan Antonio$3K
- Rushil RaoSan Antonio$3K
- Enchun LiuSan Antonio$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.